Quantitative Human WNT9B (Glycosylated) Sandwich ELISA Kit

The quantitative human WNT9B (glycosylated) sandwich ELISA kit is designed to detect human wingless type MMTV integration site family, member 9B (WNT9B) levels. WNT9B is a secreted glycoprotein that plays a role in various developmental processes, including kidney development, limb patterning, and tissue homeostasis, by activating Wnt signaling pathways. It is involved in cell fate determination and tissue morphogenesis. The kit is suitable for various biological samples such as tissue homogenates, cell lysates. Its sensitivity is 0.123 ng/mL, which can accurately detect low concentrations of WNT9B in the sample.

WNT9B

Pre-coated ELISA plate; Lyophilized standard; Biotin-labeled antibody; HRP-avidin; Various diluents; Wash buffer; TMB chromogenic substrate; Stop solution

Tissue homogenates, cell lysates

100 μL

0.123 ng/mL

Quantitative sandwich ELISA

1 ng/mL-10 ng/mL

1 h-5 h

450 nm

Store at 2-8°C for long term storage.

Human

Wingless type MMTV integration site family, member 9B

WNT9B; Wingless type MMTV integration site family, member 9B; WNT15

99

The quantitative human WNT9B (glycosylated) sandwich ELISA kit is valuable for researchers investigating kidney diseases, skeletal disorders, and cancer, where WNT9B signaling is implicated. By quantifying WNT9B, researchers can gain insights into its role in disease pathogenesis and explore potential therapeutic targets related to Wnt pathway modulation.

Intra-Assay: n=20, CV <8%;
Inter-Assay: n=20, CV <10%;

Serum sample: n=5, 80-100%;
Plasma sample: n=4, 85-100%;

The standard curve is for reference only, and a new standard curve should be generated for each set of samples tested.